Market-Moving Exclusives

EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models

EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%

EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants

EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%

EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants

EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients

EXCLUSIVE: DeFi Development Makes Record Solana Purchase, Surpasses $100 Million In Treasury Holdings

EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients

EXCLUSIVE: DeFi Development Makes Record Solana Purchase, Surpasses $100 Million In Treasury Holdings

EXCLUSIVE: Inuvo Clocks 57% Topline Growth, Margin Shrinks Due To Product Mix

EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program

Market-Moving Exclusives Recent News

EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million

Mira Pharmaceuticals to acquire SKNY in a stock-based deal valuing both firms near $30 million each, backed by third-party pipeline valuation reports.

EXCLUSIVE: Aduro's Deal With Cleanfarms Targets Farm Plastic Recycling Revolution And Scalable Sustainability

Aduro Clean Technologies Inc. (Nasdaq: ADUR) signed an MOU with Cleanfarms to explore using Aduro's HCT for chemically recycling difficult-to-process plastic waste in agriculture.

EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program

Alzamend Neuro teams up with QMENTA for five AL001 Phase 2 trials at Mass General, targeting Alzheimer's, PTSD, bipolar disorder, and more.

EXCLUSIVE: DeFi Development Corp Expands Digital Asset Portfolio, Holds $58.5 Million In Solana Tokens

DeFi Development Corp (NASDAQ:DFDV), formerly Janover Inc., announced on Tuesday that it had purchased approximately 82,404.50 Solana (CRYPTO:

EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study

Ketamir-2 from MIRA Pharmaceuticals showed no brain toxicity in rats, meeting FDA study requirements and advancing its clinical development program.

Exclusive: HF Foods Launches E-Commerce Platform For Restaurant Staff Nationwide

HF Foods Group Inc. announced a new online platform for restaurant staff to directly order specialty food products, part of their growth strategy.

EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial

Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations.

Nvidia CEO Jensen Huang Warns US Lawmakers Are Fueling Rise Of China's Huawei With Their Chip Export Bans

Nvidia CEO Jensen Huang warned U.S. lawmakers that export bans on AI chips may unintentionally benefit Huawei, allowing the Chinese tech giant to gain a competitive edge in the global AI race.

EXCLUSIVE: TransCode Therapeutics Reports Progress In Early-Stage Study For Lead Cancer Drug

TransCode Therapeutics advances Phase 1a trial of TTX-MC138 for metastatic cancer with early signs of stability and consistent PK/PD data.

EXCLUSIVE: Silo Pharma's Investigational Ketamine Implant Hits All Endpoints In Pain Study In Animal Models

Silo Pharma reported positive preclinical results for its ketamine-based implant SP-26, designed to treat chronic pain and fibromyalgia.

EXCLUSIVE: Wix And ActiveCampaign Collaborate To Boost Engagement And Marketing Automation

Wix partners with ActiveCampaign to offer an integrated solution for businesses, streamlining website and marketing operations and enhancing customer engagement.

EXCLUSIVE: SolarBank To Develop 7.2 MW Solar Project In New York

SolarBank Corp (NASDAQ: SUUN) plans to develop 7.2 MW DC solar project in NY, eligible for incentives and aiming for $0.0971/kWh compensation.

EXCLUSIVE: Beeline Breaks $1 Billion Barrier, Bets Big On AI And Short-Term Rental Surge

Beeline Holdings, parent company of Beeline Loans, surpasses $1B in closed loans. CEO says reaching milestone shows strength and value in challenging market.